AAAAAA

   
Results: 1-9 |
Results: 9
CHANGES IN BIOCHEMICAL MARKERS AND BONE MASS AFTER WITHDRAWAL OF IBANDRONATE TREATMENT - PREDICTION OF BONE MASS CHANGES DURING TREATMENT
Authors: RAVN P CHRISTENSEN JO BAUMANN C CLEMMESEN B
Citation: P. Ravn et al., CHANGES IN BIOCHEMICAL MARKERS AND BONE MASS AFTER WITHDRAWAL OF IBANDRONATE TREATMENT - PREDICTION OF BONE MASS CHANGES DURING TREATMENT, Bone, 22(5), 1998, pp. 559-564
ALENDRONATE PREVENTS POSTMENOPAUSAL BONE LOSS IN WOMEN WITHOUT OSTEOPOROSIS - A DOUBLE-BLIND, RANDOMIZED, CONTROLLED TRIAL
Authors: MCCLUNG M CLEMMESEN B DAIFOTIS A GILCHRIST NL EISMAN J WEINSTEIN RS FULEIHAN GE REDA C YATES AJ RAVN P
Citation: M. Mcclung et al., ALENDRONATE PREVENTS POSTMENOPAUSAL BONE LOSS IN WOMEN WITHOUT OSTEOPOROSIS - A DOUBLE-BLIND, RANDOMIZED, CONTROLLED TRIAL, Annals of internal medicine, 128(4), 1998, pp. 253
A 2-YEAR PHASE-II STUDY WITH 1-YEAR OF FOLLOW-UP OF RISEDRONATE (NE-58095) IN POSTMENOPAUSAL OSTEOPOROSIS
Authors: CLEMMESEN B RAVN P ZEGELS B TAQUET AN CHRISTIANSEN C REGINSTER JY
Citation: B. Clemmesen et al., A 2-YEAR PHASE-II STUDY WITH 1-YEAR OF FOLLOW-UP OF RISEDRONATE (NE-58095) IN POSTMENOPAUSAL OSTEOPOROSIS, Osteoporosis international, 7(5), 1997, pp. 488-495
HIGH BONE TURNOVER IS ASSOCIATED WITH LOW BONE MASS AND SPINAL FRACTURE IN POSTMENOPAUSAL WOMEN
Authors: RAVN P RIX M ANDREASSEN H CLEMMESEN B BIDSTRUP M GUNNES M
Citation: P. Ravn et al., HIGH BONE TURNOVER IS ASSOCIATED WITH LOW BONE MASS AND SPINAL FRACTURE IN POSTMENOPAUSAL WOMEN, Calcified tissue international, 60(3), 1997, pp. 255-260
THE EFFECT ON BONE MASS AND BONE MARKERS OF DIFFERENT DOSES OF IBANDRONATE - A NEW BISPHOSPHONATE FOR PREVENTION AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS - A 1-YEAR, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED DOSE-FINDING STUDY
Authors: RAVN P CLEMMESEN B RIIS BJ CHRISTIANSEN C
Citation: P. Ravn et al., THE EFFECT ON BONE MASS AND BONE MARKERS OF DIFFERENT DOSES OF IBANDRONATE - A NEW BISPHOSPHONATE FOR PREVENTION AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS - A 1-YEAR, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED DOSE-FINDING STUDY, Bone, 19(5), 1996, pp. 527-533
THE EFFECT ON BONE MASS AND BONE MARKERS OF IBANDRONATE TREATMENT IN POSTMENOPAUSAL OSTEOPOROSIS - A 1-YEAR, RANDOMIZED, DOUBLE-LIPID, PLACEBO-CONTROLLED DOSE-FINDING STUDY WITH 1-YEAR FOLLOW-UP
Authors: RAVN P CHRISTENSEN J CLEMMESEN B RIIS BJ CHRISTIANSEN C
Citation: P. Ravn et al., THE EFFECT ON BONE MASS AND BONE MARKERS OF IBANDRONATE TREATMENT IN POSTMENOPAUSAL OSTEOPOROSIS - A 1-YEAR, RANDOMIZED, DOUBLE-LIPID, PLACEBO-CONTROLLED DOSE-FINDING STUDY WITH 1-YEAR FOLLOW-UP, Journal of bone and mineral research, 11, 1996, pp. 654-654
BIOCHEMICAL MARKERS CAN PREDICT THE RESPONSE IN BONE MASS TO IBANDRONATE TREATMENT IN POSTMENOPAUSAL OSTEOPOROSIS
Authors: RAVN P CHRISTENSEN J CLEMMESEN B RIIS BJ CHRISTIANSEN C
Citation: P. Ravn et al., BIOCHEMICAL MARKERS CAN PREDICT THE RESPONSE IN BONE MASS TO IBANDRONATE TREATMENT IN POSTMENOPAUSAL OSTEOPOROSIS, Journal of bone and mineral research, 11, 1996, pp. 655-655
HIGH BONE TURNOVER IS ASSOCIATED WITH LOW BONE MASS AND SPINAL FRACTURE IN POSTMENOPAUSAL WOMEN
Authors: RAVN P CLEMMESEN B ANDREASSEN H RIX M GUNNES M
Citation: P. Ravn et al., HIGH BONE TURNOVER IS ASSOCIATED WITH LOW BONE MASS AND SPINAL FRACTURE IN POSTMENOPAUSAL WOMEN, Journal of bone and mineral research, 10, 1995, pp. 240-240
HUMAN GROWTH-HORMONE AND GROWTH-HORMONE RELEASING HORMONE - A DOUBLE-MASKED, PLACEBO-CONTROLLED STUDY OF THEIR EFFECTS ON BONE METABOLISM IN ELDERLY WOMEN
Authors: CLEMMESEN B OVERGAARD K RIIS B CHRISTIANSEN C
Citation: B. Clemmesen et al., HUMAN GROWTH-HORMONE AND GROWTH-HORMONE RELEASING HORMONE - A DOUBLE-MASKED, PLACEBO-CONTROLLED STUDY OF THEIR EFFECTS ON BONE METABOLISM IN ELDERLY WOMEN, Osteoporosis international, 3(6), 1993, pp. 330-336
Risultati: 1-9 |